The Oncology Institute, Inc. TOI Medical supplies and other — Direct costs
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by The Oncology Institute, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization.
The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Oncology Institute, Inc.'s medical supplies and other — direct costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Oncology Institute, Inc.'s medical supplies and other — direct costs?
- The Oncology Institute, Inc. (TOI) reported medical supplies and other — direct costs of $8.28M in Q1 2026.
- What does medical supplies and other — direct costs mean?
- This metric represents the total direct costs associated with the procurement and utilization of medical supplies and ancillary services within a specific business segment. It captures the essential expenditures required to deliver patient care, including consumables and specialized materials necessary for oncology treatments. Monitoring this figure helps assess the cost structure and supply chain efficiency of the segment's service delivery model.